Monopar Therapeutics
MNPR
#7832
Rank
S$0.32 B
Marketcap
$52.89
Share price
-0.88%
Change (1 day)
1,095.31%
Change (1 year)

EPS for Monopar Therapeutics (MNPR)

EPS in 2023 (TTM): -$1.05

According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.01. In 2022 the company made an earnings per share (EPS) of -$1.09 a decrease over its 2021 EPS that were of -$0.97.

EPS history for Monopar Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.05-3.29%
2022-$1.0912.16%
2021-$0.9727.59%
2020-$0.7643.71%
2019-$0.5333.52%
2018-$0.40-80.97%
2017-$2.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.85 183.12%๐Ÿ‡บ๐Ÿ‡ธ USA